HR1 group | HR2 group | p Value | |
---|---|---|---|
Gender (male/female) | 43/8 | 7/1 | 0.816 |
Age (year) | 47.06±8.54 | 48.13±7.55 | 0.799 |
Transplant year (before 2008/after 2008) | 19/32 | 1/7 | 0.330 |
Blood type | 0.166 | ||
A | 17 | 1 | |
AB | 6 | 0 | |
B | 15 | 2 | |
O | 13 | 5 | 0.337 |
Blood type incompatible | 9 | 0 | 0.602 |
Preoperative AFP level, median (IQR), ng/mL | 232.6 (12.8–1176.1) | 323.7 (32.1–756.2) | 0.775 |
MELD score | 10 (7–15) | 10.5 (7–15.25) | 0.911 |
TNM classification | 0.504 | ||
I | 13 | 2 | |
II | 11 | 3 | |
III | 19 | 1 | |
IV | 8 | 2 | |
Child-Pugh score | 7 (5–9) | 7 (5.25–9) | 0.781 |
Diameter of largest tumour, median (IQR), cm | 3 (2–5) | 3 (2.13–4.38) | 0.602 |
Number of tumours, median (IQR) | 2 (1–3) | 2 (1–10.5) | 0.588 |
Sum of tumour diameters, median (IQR), cm | 4.75 (3.00–7.88) | 4 (1.2–12.75) | 0. 873 |
Macrovascular invasion | 18 | 1 | 0.381 |
Cold ischaemia time (hours) | 8.8 (7–11.18) | 11.58 (7.48–12.48) | 0.163 |
Warm ischaemia time (minutes) | 4.5 (3.5–5.00) | 5.00 (4.25–5.00) | 0.105 |
Intraoperative blood loss (mL) | 2500 (1500–4500) | 5500 (2500–10 000) | 0.460 |
AFP, α-fetoprotein; HR, hepatic resection; MELD, Model for End-Stage Liver Disease; TNM, tumour node metastasis.